Endovascular Management of Arteriovenous Malformations

Author(s):  
Shailesh Gaikwad ◽  
NK Mishra
2020 ◽  
Author(s):  
Ahmed Attia Ahmed Hassan ◽  
Ali Hassan Elmokadem ◽  
Ahmed Bahaa Elden Elserwi ◽  
Mohamed Metwally Abo El Atta ◽  
Talal Ahmed Youssef Amer

2014 ◽  
Vol 60 (6) ◽  
pp. 1723-1724
Author(s):  
Michael B. Silva ◽  
Charlie C. Cheng ◽  
Grant Fankhauser ◽  
Zulfiqar F. Cheema

Author(s):  
Badih Daou ◽  
Pascal Jabbour

Endovascular neurosurgery has evolved dramatically since the first description of aneurysm coiling in 1991 and is now employed as a primary treatment strategy for managing a multitude of cerebrovascular pathologies, including aneurysms, arteriovenous malformations (AVMs), and acute ischemic stroke. The endovascular approach offers an attractive, minimally invasive alternative for aneurysm treatment with low procedure-related morbidity and mortality. The durability and long-term efficacy of endovascular interventions is continuously evolving, especially with the introduction of newer coils, stents, and flow-diversion techniques. Endovascular management of AVMs can be used for presurgical embolization, preradiosurgical intervention, or palliative embolization or as a primary treatment for curative embolization, depending on the characteristics of the lesion. Advances in endovascular management of acute stroke have further increased the therapeutic window of recombinant tissue plasminogen activator administration using the intraarterial route and have led to the introduction of new devices for clot removal and vessel recanalization.


2014 ◽  
Vol 25 (3) ◽  
pp. S187
Author(s):  
A.K. Abdel Aal ◽  
M.W. Estafanous ◽  
L. Anis Estafanous ◽  
R. Oser ◽  
S. Saddekni ◽  
...  

2000 ◽  
Vol 93 (2) ◽  
pp. 304-308 ◽  
Author(s):  
Andrew J. Molyneux ◽  
Stuart C. Coley

✓ In this paper the authors describe the first use of a new liquid embolic agent (Onyx) to treat spinal cord arteriovenous malformations (AVMs). Because its properties make it more predictable to use than currently available liquid agents, the authors believe that this material has great potential in the endovascular management of both spinal cord and brain AVMs. This very promising agent merits further clinical study.


Sign in / Sign up

Export Citation Format

Share Document